---
title: "Edwards Lifesciences to strengthen structural heart business after sale of Critical Care group"
date: "2024-06-03T14:55:09.000Z"
publishedDate: "3 juin 2024"
summary: "Edwards Lifesciences has announced that it has entered into a definitive agreement to sell its Critical Care product group to BD in an all-cash transaction valued at US$4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care."
importance: ""
sourceUrl: "https://cardiovascularnews.com/edwards-lifesciences-to-strengthen-structural-heart-business-after-sale-of-critical-care-group/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-06-03-edwards-lifesciences-to-strengthen-structural-heart-business-after-sale-of-critical-care-group"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/03/edwards-corporate-2-large.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/edwards-lifesciences-to-strengthen-structural-heart-business-after-sale-of-critical-care-group/"
---

![Edwards Lifesciences to strengthen structural heart business after sale of Critical Care group](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/03/edwards-corporate-2-large.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/edwards-lifesciences-to-strengthen-structural-heart-business-after-sale-of-critical-care-group/*

## L’essentiel

Edwards Lifesciences has announced that it has entered into a definitive agreement to sell its Critical Care product group to BD in an all-cash transaction valued at US$4.2 billion. With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care.

## Lien source

https://cardiovascularnews.com/edwards-lifesciences-to-strengthen-structural-heart-business-after-sale-of-critical-care-group/
